Medication
Dimenhydrinate Injection Usp
DIN 02536536 · Sandoz Canada Incorporated Likely a generic
What it is
- Active ingredients
- Dimenhydrinate — 50 mg
- Form and routes
- Solution · Intramuscular, Intravenous
- Schedule
- ETHICAL
- Authorised since
- 2024-08-27
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Gravol Tablets
- Dimenhydrinate Injection Usp
- Confab Dimenhydrinate 50 MG
- Travel Tabs 50 MG
- Anti-Nauseant
- Jamp-Dimenhydrinate
- Gravol Liquid Gels
- Gravol Chewables
- Dimenhydrinate Injection Usp
- Dimenhydrinate Injection Usp
- Gaviscon Nausea
- Anti-Nauseant Liquid Gels
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Ontario Drug Benefit coverage
As of 31 July 2026Limited Use benefit Part XII
Ontario lists this product as a Limited Use benefit — Part XII of the Formulary/CDI. ODB pays for it only in the specific circumstances Ontario sets out against it, and the prescription has to carry a Limited Use code from the prescriber.
The criteria are set by Ontario and are not reproduced here — they are a matter for the prescriber.
- What ODB pays per unit
- $1.3800
This is what the Ontario Drug Benefit program reimburses a pharmacy for one unit, as of 31 July 2026. A deductible and a co-payment sit on top of it and differ by program — ODB, the Trillium Drug Program and the seniors co-payment each work differently — so it is not the figure anyone is charged at a counter. It also says nothing about private, workplace or federal coverage.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Respiratory system
- ATC code
- R06AA11
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of R06AA11, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.
Search Health Canada recalls for Dimenhydrinate Injection Usp →